Bottom line
RXD vs MUU: the short answer
RXD (ProShares UltraShort Health Care) and MUU (Direxion Daily MU Bull 2X ETF) are both etfs.
RXD is cheaper at 0.95% vs 1.01% — a difference of $6.00 a year per $10,000 invested.
Over one year, MUU returned +595.1% vs −21.6% for RXD.
Updated Nov 19, 2026
RXD vs MUU side by side
| RXD | MUU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.95% | 1.01% |
| Annual cost per $10k | $95 | $101 |
| 10-yr cost on $10k (prospectus) | $4,430 | $1,236 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | −21.6% | +595.1% |
| 5-yr return (annualized) | −11.9% | — |
| 10-yr return (annualized) | −19.9% | — |
| Best quarter | +27.0% | +153.5% |
| Worst quarter | −29.5% | −5.9% |
| Net assets (fund) | $5.3M | $3.4B |
| Number of holdings | 10 | 13 |
| Portfolio turnover | % | 33% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | RXD | MUU | Difference |
|---|---|---|---|
| 2025 | −21.6% | +595.1% | −616.7% |
Source: Fund prospectus bar charts
Holdings overlap
6 of RXD's top 10 holdings also appear in MUU's top 13.
| Holding | RXD | MUU |
|---|---|---|
| N/a | 1.14% | -12.38% |
| N/a | 0.33% | -12.38% |
| N/a | -0.34% | -12.38% |
| N/a | -0.41% | -12.38% |
| N/a | -0.54% | -12.38% |
| N/a | -1.63% | -12.38% |
Source: SEC Form N-PORT
RXD top 10
- Repurchase Agreement — 37.33%
- Repurchase Agreement — 23.49%
- Repurchase Agreement — 17.62%
- Repurchase Agreement — 12.92%
- N/a — 1.14%
- N/a — 0.33%
- N/a — -0.34%
- N/a — -0.41%
- N/a — -0.54%
- N/a — -1.63%
MUU top 10
- Dreyfus — 46.83%
- Dreyfus — 42.68%
- Goldman Sachs Liq Es Fd A — 22.12%
- Goldman Financial — 14.22%
- Micron Technology Inc — 12.60%
- N/a — -0.13%
- N/a — -1.19%
- N/a — -1.57%
- N/a — -2.40%
- N/a — -4.21%
FAQ
What is the difference between RXD and MUU?
Which is cheaper, RXD or MUU?
Should I own both RXD and MUU?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.